These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 4174197)
21. Effect of oral contraceptives on the variations in serum-iron during the menstrual cycle. Mardell M; Zilva JF Lancet; 1967 Dec; 2(7530):1323-5. PubMed ID: 4170025 [No Abstract] [Full Text] [Related]
22. Pregnancy and progeny. Banks AL Int J Fertil; 1968; 13(4):346-8. PubMed ID: 5700391 [No Abstract] [Full Text] [Related]
24. Effect of 19-norsteroids on the motility of human fallopian tubes. Jakobovits A; Gecse A; Piukovich I; Szontágh F; Karády I Int J Fertil; 1970; 15(1):36-9. PubMed ID: 5416878 [No Abstract] [Full Text] [Related]
25. The effects of some ovulation inhibitors on the different plasma lipid fractions. Brody S; Kerstell J; Nilsson L; Svanborg A Acta Med Scand; 1968; 183(1-2):1-7. PubMed ID: 5669819 [No Abstract] [Full Text] [Related]
26. Effect of oral contraceptive steroids on jejunal pyruvate kinase and adenyl cyclase activities. Stifel FB; Greene HL; Herman RH Endocrinology; 1971 Sep; 89(3):896-7. PubMed ID: 4105307 [No Abstract] [Full Text] [Related]
27. OPTIMUM DOSAGE FOR ESTROGEN-PROGESTOGEN BALANCE TO INHIBIT OVULATION. JACKSON MC; LINN R Int J Fertil; 1964; 9():75-86. PubMed ID: 14106271 [No Abstract] [Full Text] [Related]
28. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol. Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418 [TBL] [Abstract][Full Text] [Related]
29. The morphologic effects of oral contraceptive agents on the cervix. Gall SA; Bourgeois CH; Maguire R JAMA; 1969 Mar; 207(12):2243-7. PubMed ID: 5820323 [No Abstract] [Full Text] [Related]
30. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components. Rangnekar KN; Rao SS; Joshi UM Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295 [TBL] [Abstract][Full Text] [Related]
32. Acute phase protein in serum of women using hormonal contraceptives. Schumacher GF Science; 1966 Aug; 153(3738):901-2. PubMed ID: 4161891 [TBL] [Abstract][Full Text] [Related]
33. Effect of ethynodiol diacetate and combination--type oral contraceptive compounds on carbohydrate metabolism. I. Six month intravenous glucose tolerance study. Goldman JA Diabetologia; 1975 Feb; 11(1):45-8. PubMed ID: 1140518 [TBL] [Abstract][Full Text] [Related]
35. Plasma triglyceride turnover during use of oral contraceptives. Kekki M; Nikkilä EA Metabolism; 1971 Sep; 20(9):878-89. PubMed ID: 4105291 [No Abstract] [Full Text] [Related]
36. A visual aid to the classification of oral contraceptives. Law B; Mumford JP; Hoonakker EW Curr Med Res Opin; 1974; 2(1):7-12. PubMed ID: 4135338 [TBL] [Abstract][Full Text] [Related]
37. The effects of hormonal contraceptives on the human periodontium. Knight GM; Wade AB J Periodontal Res; 1974; 9(1):18-22. PubMed ID: 4277696 [TBL] [Abstract][Full Text] [Related]
38. ABSENCE OF HEPATIC IMPAIRMENT IN LONG-TERM ORAL-CONTRACEPTIVE USERS. SWYER GI; LITTLE V Br Med J; 1965 May; 1(5447):1412-4. PubMed ID: 14287002 [No Abstract] [Full Text] [Related]
39. The relative expressed estrogenicity of oral contraceptives. Rooks WH; Kugler SL; Dorfman RI Fertil Steril; 1968; 19(3):419-23. PubMed ID: 5647620 [TBL] [Abstract][Full Text] [Related]
40. [Cytological studies of the uterine endothelium treated with synthetic luteum hormones]. Shigenaga Y Nihon Naibunpi Gakkai Zasshi; 1966 Aug; 42(5):540-55. PubMed ID: 4165515 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]